[interactive Nuggets] Changchun High And New Technology Industries (Group) Inc(000661) : the bidding process for centralized drug procurement has not been officially started

Changchun High And New Technology Industries (Group) Inc(000661) : the bidding procedure for centralized drug procurement has not been officially started

Changchun High And New Technology Industries (Group) Inc(000661) (000661) said on the interactive platform that the company continues to pay attention to policy changes. At present, the bidding process for centralized drug procurement has not been officially started, and the specific impact will depend on the actual participation in the bidding, the winning result, the winning price, etc. the subsequent matters and the impact on the company are still uncertain, At present, there is no expectation that it will have a serious impact on the company's operating performance. The company will actively pay attention to the follow-up progress, carefully study the provisions of relevant documents and reasonably formulate the implementation plan.

Jinke Zhejiang Jinke Tom Culture Industry Co.Ltd(300459) signed a strategic cooperation agreement with a subsidiary of the second Academy of Aerospace Science and industry of China

Recently, Zhejiang Jinke Zhejiang Jinke Tom Culture Industry Co.Ltd(300459) Network Technology Co., Ltd., a subsidiary of Jinke Zhejiang Jinke Tom Culture Industry Co.Ltd(300459) , signed a strategic cooperation agreement with aerospace science and Industry Space Engineering Development Co., Ltd. and Beijing Ruiyi culture media Co., Ltd. The three parties will comprehensively carry out in-depth cooperation in the fields of IP authorization, space authorization and joint brand marketing around the company's "talking Zhejiang Jinke Tom Culture Industry Co.Ltd(300459) family" series IP.

Yunnan Baiyao Group Co.Ltd(000538) : strictly control the investment scale in the secondary market, gradually reduce the position, and do not continue to increase

Yunnan Baiyao Group Co.Ltd(000538) during the institutional research, the company fully listened to the opinions and suggestions of the majority of investors on the development of the company, and strictly controlled the investment scale of the secondary market on the basis of the original risk control measures. In 2022, within the limit approved by the board of directors, the company will gradually reduce its positions and will not continue to increase its holdings.

Loctek Ergonomic Technology Corp(300729) : the profit side of the company is mainly affected by sea freight, which is still at a high level

Loctek Ergonomic Technology Corp(300729) said during the institutional research that the current external environment situation is still severe. The profit side of the company is mainly affected by sea freight, which is still high since 21q3. If the sea freight and exchange rate improve in the future, it will also be reflected in the company's profit margin.

Lianchuang superconducting: high temperature superconducting induction heating realizes the application in the field of aviation high-end aluminum profile forging

According to Lianchuang superconducting news, the megawatt high-temperature superconducting induction heating equipment for high-end aviation aluminum forging of Chinalco group has been installed and debugged at the production site, and all the high-temperature superconducting induction heating equipment operates normally, fully reaching the expected goal, and successfully forging the world's first aviation 5-series aluminum alloy workpiece based on superconducting induction heating, It will begin to enter the substantive heating and forging production process. High temperature superconducting induction heating equipment will effectively help the development of national military and aerospace high-end core parts. Lianchuang superconductor is jointly invested and established by Jiangxi Electronics Group and Jianxi Lianchuang Opto-Electronic Science&Technology Co.Ltd(600363) .

Apeloa Pharmaceutical Co.Ltd(000739) was selected into the list of the first batch of manufacturing "cloud enterprises" in Zhejiang Province

Recently, the Department of economy and information technology of Zhejiang Province released the list of the first batch of manufacturing "cloud enterprises" in Zhejiang Province, Apeloa Pharmaceutical Co.Ltd(000739) on the list. It is understood that the "cloud enterprise" in the manufacturing industry refers to comprehensively building a core business system based on the cloud deployment of digital infrastructure, taking data resources as the key element, creating a cloud Digital Collaborative ecosystem inside and outside the enterprise and upstream and downstream of the industrial chain, and constantly improving the efficiency of resource allocation and the intelligent level of production management, so as to achieve competitiveness Develop manufacturing enterprises with significantly improved quality and efficiency.

Bluefocus Intelligent Communications Group Co.Ltd(300058) : the subsidiary blue universe signed a contract to settle in Beijing Urban sub center

On January 19, the conference on promoting the high-quality development of urban sub central industries in Beijing was held. At the meeting, Beijing Tongzhou District Investment Promotion Center and Bluefocus Intelligent Communications Group Co.Ltd(300058) signed the cooperation framework agreement of the wholly-owned subsidiary blue universe landing City sub center, and Luo Bin, President of Bluefocus Intelligent Communications Group Co.Ltd(300058) group, attended the signing ceremony. As the main position of Bluefocus Intelligent Communications Group Co.Ltd(300058) focusing on exploring the relevant investment and operation business of yuanuniverse, blue universe has become one of the first heavyweight yuanuniverse enterprises settled in the sub center of Beijing.

Zhejiang Conba Pharmaceutical Co.Ltd(600572) : the major negative impact of centralized purchase price reduction on the company has been basically implemented, and the positive impact has begun to show

Zhejiang Conba Pharmaceutical Co.Ltd(600572) according to the institutional research, the hospital procurement and use of pantoprazole sodium enteric coated tablets and Zhenshiming sodium hyaluronate eye drops, the company's fourth batch of "barefoot" products, has begun in May 2021. Among them, pantoprazole enteric coated capsules had a sales revenue of about 70 million yuan in 2021 and sodium hyaluronate eye drops had a sales revenue of about 30 million yuan in 2021, These two products will continue to be sold in large quantities in the future. Based on the company's existing varieties and the trend of drug centralized purchase policy, it should be said that the significant negative impact of centralized purchase and price reduction on the company has basically been implemented, and the positive impact has begun to appear. Therefore, the impact of centralized purchase of chemical drugs on the company is generally neutral.

Topchoice Medical Co.Inc(600763) : intensive dental implant purchase affects the cost of oral service. The company launched low-cost implant business

Topchoice Medical Co.Inc(600763) said during the institutional research that the intensive purchase of dental implants affects the cost of dental services. The company actively responded to the industrial policies and common prosperity actions, launched the low-cost dental implant business, promoted the concept of Tongce high school low dental supermarket, added low-cost implant projects on the basis of the original business, and promoted the growth of the company's share in the low-cost implant market, It plays a positive role in promoting the overall improvement of the company's planting business.

Hubei Feilihua Quartz Glass Co.Ltd(300395) : the quartz glass fiber business maintains a good development trend, with sufficient orders

Hubei Feilihua Quartz Glass Co.Ltd(300395) (300395) said on the interactive platform on January 20 that driven by the rapid development of aerospace field, the company's quartz glass fiber business maintained a good development trend and had sufficient orders.

Shanghai Baolong Automotive Corporation(603197) : about 25 sensing fixed-point projects have been obtained and are expected to be mass produced in 2022

Shanghai Baolong Automotive Corporation(603197) (603197) said on the interactive platform on January 20 that about 25 sensing fixed-point projects obtained by the company are expected to be mass produced in 2022. Millimeter wave radar has achieved mass production by the end of the 21st century, and it is expected that orders will be further increased in the 22nd year.

- Advertisment -